The significance of valine 33 as a ligand-specific epitope of transforming growth factor alpha
Although binding of epidermal growth factor (EGF) and transforming growth factor alpha (TGFalpha) to the EGF receptor (EGFR) is mutually competitive, their binding is not identical, and their biological activities are not always equivalent. To probe for ligand-specific interactions, we have synthesi...
Saved in:
Published in: | The Journal of biological chemistry Vol. 271; no. 26; pp. 15367 - 15372 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
1996
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Although binding of epidermal growth factor (EGF) and transforming growth factor alpha (TGFalpha) to the EGF receptor (EGFR) is mutually competitive, their binding is not identical, and their biological activities are not always equivalent. To probe for ligand-specific interactions, we have synthesized analogues of TGFalpha with modifications to the residue lying between the fourth and fifth cysteines (the "hinge"). Although this residue lies in a structurally conserved region of the protein, it is not conserved within the EGFR ligand family. Our results show that in TGFalpha there is a preference for a bulky hydrophobic hinge residue; this contrasts with EGF, for which a hydrogen bond donor functionality is preferred. Sequence analysis of the human EGFR ligands revealed that the nature of the hinge residue correlated with the sequence in the B-loop beta-sheet. As this region is an important determinant in recognition of TGFalpha by the chicken EGFR, we assessed the mitogenicity of the TGFalpha hinge mutants, as well as the other EGFR ligands, using chicken embryo fibroblasts. The preference of the chicken EGFR for TGFalpha hinge mutants with hydrophobic side chains paralleled that of the human EGFR. Betacellulin and heparin-binding EGF-like growth factor also possess an hydrophobic hinge; both were at least as potent as TGFalpha for chicken embryo fibroblasts. EGF and amphiregulin, both with hydrogen bond donor functionalities at their hinge, displayed markedly decreased in potency by comparison with TGFalpha. We propose that EGFR ligands can be subclassified into TGFalpha-like and EGF-like and that this is of functional significance, identifying a potential mechanism whereby EGFR can discriminate between its ligands. |
---|---|
AbstractList | Although binding of epidermal growth factor (EGF) and transforming growth factor alpha (TGFalpha) to the EGF receptor (EGFR) is mutually competitive, their binding is not identical, and their biological activities are not always equivalent. To probe for ligand-specific interactions, we have synthesized analogues of TGFalpha with modifications to the residue lying between the fourth and fifth cysteines (the "hinge"). Although this residue lies in a structurally conserved region of the protein, it is not conserved within the EGFR ligand family. Our results show that in TGFalpha there is a preference for a bulky hydrophobic hinge residue; this contrasts with EGF, for which a hydrogen bond donor functionality is preferred. Sequence analysis of the human EGFR ligands revealed that the nature of the hinge residue correlated with the sequence in the B-loop beta-sheet. As this region is an important determinant in recognition of TGFalpha by the chicken EGFR, we assessed the mitogenicity of the TGFalpha hinge mutants, as well as the other EGFR ligands, using chicken embryo fibroblasts. The preference of the chicken EGFR for TGFalpha hinge mutants with hydrophobic side chains paralleled that of the human EGFR. Betacellulin and heparin-binding EGF-like growth factor also possess an hydrophobic hinge; both were at least as potent as TGFalpha for chicken embryo fibroblasts. EGF and amphiregulin, both with hydrogen bond donor functionalities at their hinge, displayed markedly decreased in potency by comparison with TGFalpha. We propose that EGFR ligands can be subclassified into TGFalpha-like and EGF-like and that this is of functional significance, identifying a potential mechanism whereby EGFR can discriminate between its ligands. Although binding of epidermal growth factor (EGF) and transforming growth factor alpha (TGF alpha ) to the EGF receptor (EGFR) is mutually competitive, their binding is not identical, and their biological activities are not always equivalent. To probe for ligand-specific interactions, we have synthesized analogues of TGF alpha with modifications to the residue lying between the fourth and fifth cysteines (the "hinge"). Although this residue lies in a structurally conserved region of the protein, it is not conserved within the EGFR ligand family. Our results show that in TGF alpha there is a preference for a bulky hydrophobic hinge residue; this contrasts with EGF, for which a hydrogen bond donor functionality is preferred. Sequence analysis of the human EGFR ligands revealed that the nature of the hinge residue correlated with the sequence in the B-loop beta -sheet. As this region is an important determinant in recognition of TGF alpha by the chicken EGFR, we assessed the mitogenicity of the TGF alpha hinge mutants, as well as the other EGFR ligands, using chicken embryo fibroblasts. The preference of the chicken EGFR for TGF alpha hinge mutants with hydrophobic side chains paralleled that of the human EGFR. Betacellulin and heparin-binding EGF-like growth factor also possess an hydrophobic hinge; both were at least as potent as TGF alpha for chicken embryo fibroblasts. EGF and amphiregulin, both with hydrogen bond donor functionalities at their hinge, displayed markedly decreased in potency by comparison with TGF alpha . We propose that EGFR ligands can be subclassified into TGF alpha -like and EGF-like and that this is of functional significance, identifying a potential mechanism whereby EGFR can discriminate between its ligands. |
Author | Collins, J Richter, A Drummond, D R Puddicombe, S M Wood, L Chamberlin, S G MacGarvie, J Davies, D E |
Author_xml | – sequence: 1 givenname: S M surname: Puddicombe fullname: Puddicombe, S M organization: Cancer Research Campaign Medical Oncology Unit, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom – sequence: 2 givenname: S G surname: Chamberlin fullname: Chamberlin, S G – sequence: 3 givenname: J surname: MacGarvie fullname: MacGarvie, J – sequence: 4 givenname: A surname: Richter fullname: Richter, A – sequence: 5 givenname: D R surname: Drummond fullname: Drummond, D R – sequence: 6 givenname: J surname: Collins fullname: Collins, J – sequence: 7 givenname: L surname: Wood fullname: Wood, L – sequence: 8 givenname: D E surname: Davies fullname: Davies, D E |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8663070$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kDtPwzAUhT0UlbawsyB5YkvwI7GTEVW8pEoMdMayHTt1ldjBTkH8e0JbcZezfOdI91uCmQ_eAHCDUY4RL-73SueE45ywHJeU8RlYIERwVpOyugTLlPZouqLGczCvGKOIowX42O4MTK71zjotvTYwWPglO-cNpBTKBCXsXCt9k6XB6D8KmsGNYTiSY5Q-2RB751vYxvA97qCVegwRym7YyStwYWWXzPU5V-D96XG7fsk2b8-v64dNpgtGxkzj0mCirKwbq1WheK1ZQ1llKmI510ppjtD0h7WalliZqmpqqhCrUSUJpytwd1odYvg8mDSK3iVtuk56Ew5J4JKVFa7pBKITqGNIKRorhuh6GX8ERuJPopgkikmiIEwcJU6V2_P2QfWm-S-cDdJfOlRyKw |
CitedBy_id | crossref_primary_10_1016_S1097_2765_00_80008_8 crossref_primary_10_1016_j_jbc_2021_100872 crossref_primary_10_1080_07391102_1999_10508370 crossref_primary_10_1002_pro_3023 crossref_primary_10_1002__SICI_1097_4644_19990101_72_1_16__AID_JCB3_3_0_CO_2_X crossref_primary_10_1074_jbc_273_19_11667 crossref_primary_10_1016_S0014_5793_03_01005_6 crossref_primary_10_1074_jbc_273_19_11675 crossref_primary_10_1074_jbc_271_48_30392 crossref_primary_10_1016_S0006_291X_02_00585_5 |
Cites_doi | 10.1038/257325a0 10.1093/protein/6.6.651 10.1016/S0959-440X(05)80111-3 10.1016/0014-5793(92)80279-P 10.1074/jbc.270.3.1015 10.1002/jcb.240460307 10.1006/bbrc.1995.1100 10.1073/pnas.85.17.6528 10.1074/jbc.270.4.1612 10.1111/j.1399-3011.1991.tb00762.x 10.1016/0022-2836(92)90697-I 10.1172/JCI112202 10.1016/0167-4889(94)00224-3 10.1038/bjc.1986.39 10.1016/S0079-6603(08)60055-0 10.1016/0006-2952(94)90444-8 10.1016/0378-1119(85)90120-9 10.1016/0006-2952(94)00423-J 10.1091/mbc.2.8.599 10.1126/science.8456283 10.1016/0378-1119(91)90152-2 10.1073/pnas.82.2.488 10.1016/S0021-9258(19)44568-7 10.1016/S0021-9258(17)43958-5 10.1016/0955-2235(89)90038-0 10.1016/S0021-9258(18)42682-8 10.1021/bi00441a033 10.1126/science.7529940 10.1016/0076-6879(91)94004-V 10.1126/science.2422759 10.1016/0378-1119(90)90351-Q |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TO H94 |
DOI | 10.1074/jbc.271.26.15367 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitleList | MEDLINE Oncogenes and Growth Factors Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EndPage | 15372 |
ExternalDocumentID | 10_1074_jbc_271_26_15367 8663070 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | --- -DZ -ET -~X .55 .GJ 0R~ 0SF 186 18M 2WC 3O- 53G 5BI 5GY 5RE 5VS 6TJ 79B 85S AAEDW AAFWJ AALRI AARDX AAXUO AAYOK ABDNZ ABOCM ABPPZ ABRJW ABTAH ACGFO ACNCT ADBBV ADIYS ADVLN AENEX AEXQZ AFFNX AFOSN AFPKN AI. AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BTFSW C1A CGR CJ0 CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F20 F5P FA8 FDB FRP GROUPED_DOAJ GX1 H13 HH5 IH2 J5H KQ8 L7B MVM N9A NHB NPM OHT OK1 P-O P0W P2P R.V RHF RHI RNS ROL RPM SJN TBC TN5 TR2 UHB UPT UQL VH1 VQA W8F WH7 WHG WOQ X7M XJT XSW Y6R YQT YSK YWH YYP YZZ ZGI ZY4 ~02 ~KM 29J 34G 39C 4.4 41~ AAYJJ AAYXX ABFSI ACSFO ACYGS ADNWM AOIJS BAWUL CITATION E.L HYE QZG UKR ZE2 7TO H94 |
ID | FETCH-LOGICAL-c462t-c15e12bfa9dfcb4b79c6d368e82f77cbbc700925ffc351be88d93b06908a273 |
ISSN | 0021-9258 |
IngestDate | Fri Oct 25 02:23:16 EDT 2024 Fri Aug 23 03:45:12 EDT 2024 Sat Sep 28 08:30:07 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 26 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c462t-c15e12bfa9dfcb4b79c6d368e82f77cbbc700925ffc351be88d93b06908a273 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | http://www.jbc.org/article/S0021925818360678/pdf |
PMID | 8663070 |
PQID | 15658193 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_15658193 crossref_primary_10_1074_jbc_271_26_15367 pubmed_primary_8663070 |
PublicationCentury | 1900 |
PublicationDate | 1996-00-00 |
PublicationDateYYYYMMDD | 1996-01-01 |
PublicationDate_xml | – year: 1996 text: 1996-00-00 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of biological chemistry |
PublicationTitleAlternate | J Biol Chem |
PublicationYear | 1996 |
References | Lax (10.1074/jbc.271.26.15367_bib15) 1988; 8 Schreiber (10.1074/jbc.271.26.15367_bib10) 1986; 232 Shing (10.1074/jbc.271.26.15367_bib5) 1993; 259 Stern (10.1074/jbc.271.26.15367_bib12) 1985; 76 Campbell (10.1074/jbc.271.26.15367_bib6) 1989; 1 Clackson (10.1074/jbc.271.26.15367_bib35) 1995; 267 Winkler (10.1074/jbc.271.26.15367_bib9) 1989; 28 Gan (10.1074/jbc.271.26.15367_bib13) 1987; 242 Hommel (10.1074/jbc.271.26.15367_bib8) 1992; 227 Holt (10.1074/jbc.271.26.15367_bib26) 1994; 47 Campbell (10.1074/jbc.271.26.15367_bib29) 1993; 3 Violand (10.1074/jbc.271.26.15367_bib27) 1991; 37 Cowley (10.1074/jbc.271.26.15367_bib19) 1986; 53 Campion (10.1074/jbc.271.26.15367_bib17) 1993; 6 Hooper (10.1074/jbc.271.26.15367_bib34) 1995; 206 Shoyab (10.1074/jbc.271.26.15367_bib3) 1988; 85 Sherman (10.1074/jbc.271.26.15367_bib24) 1991; 194 Gregory (10.1074/jbc.271.26.15367_bib2) 1975; 257 Engler (10.1074/jbc.271.26.15367_bib31) 1991; 11 Mitamura (10.1074/jbc.271.26.15367_bib33) 1995; 270 Ebner (10.1074/jbc.271.26.15367_bib14) 1991; 2 Yanisch-Perron (10.1074/jbc.271.26.15367_bib21) 1985; 33 Campion (10.1074/jbc.271.26.15367_bib7) 1995; 49 Kunkel (10.1074/jbc.271.26.15367_bib22) 1985; 82 Adam (10.1074/jbc.271.26.15367_bib28) 1995; 1266 Massagué (10.1074/jbc.271.26.15367_bib1) 1983; 258 Savage (10.1074/jbc.271.26.15367_bib18) 1972; 247 Landt (10.1074/jbc.271.26.15367_bib23) 1990; 96 Richter (10.1074/jbc.271.26.15367_bib25) 1995; 49 Clare (10.1074/jbc.271.26.15367_bib20) 1991; 105 Hollenberg (10.1074/jbc.271.26.15367_bib11) 1989; 248 Matsunami (10.1074/jbc.271.26.15367_bib32) 1991; 46 Koide (10.1074/jbc.271.26.15367_bib30) 1992; 302 Higashiyama (10.1074/jbc.271.26.15367_bib4) 1991; 267 Richter (10.1074/jbc.271.26.15367_bib16) 1995; 270 |
References_xml | – volume: 257 start-page: 325 year: 1975 ident: 10.1074/jbc.271.26.15367_bib2 publication-title: Nature doi: 10.1038/257325a0 contributor: fullname: Gregory – volume: 6 start-page: 651 year: 1993 ident: 10.1074/jbc.271.26.15367_bib17 publication-title: Protein Eng. doi: 10.1093/protein/6.6.651 contributor: fullname: Campion – volume: 3 start-page: 385 year: 1993 ident: 10.1074/jbc.271.26.15367_bib29 publication-title: Curr. Opin. Struct. Biol. doi: 10.1016/S0959-440X(05)80111-3 contributor: fullname: Campbell – volume: 302 start-page: 39 year: 1992 ident: 10.1074/jbc.271.26.15367_bib30 publication-title: FEBS Lett. doi: 10.1016/0014-5793(92)80279-P contributor: fullname: Koide – volume: 270 start-page: 1015 year: 1995 ident: 10.1074/jbc.271.26.15367_bib33 publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.3.1015 contributor: fullname: Mitamura – volume: 8 start-page: 1970 year: 1988 ident: 10.1074/jbc.271.26.15367_bib15 publication-title: Mol. Cell. Biol. contributor: fullname: Lax – volume: 46 start-page: 242 year: 1991 ident: 10.1074/jbc.271.26.15367_bib32 publication-title: J. Cell. Biochem. doi: 10.1002/jcb.240460307 contributor: fullname: Matsunami – volume: 206 start-page: 710 year: 1995 ident: 10.1074/jbc.271.26.15367_bib34 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1995.1100 contributor: fullname: Hooper – volume: 85 start-page: 6528 year: 1988 ident: 10.1074/jbc.271.26.15367_bib3 publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.85.17.6528 contributor: fullname: Shoyab – volume: 270 start-page: 1612 year: 1995 ident: 10.1074/jbc.271.26.15367_bib16 publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.4.1612 contributor: fullname: Richter – volume: 37 start-page: 463 year: 1991 ident: 10.1074/jbc.271.26.15367_bib27 publication-title: Int. J. Pept. Protein Res. doi: 10.1111/j.1399-3011.1991.tb00762.x contributor: fullname: Violand – volume: 227 start-page: 271 year: 1992 ident: 10.1074/jbc.271.26.15367_bib8 publication-title: J. Mol. Biol. doi: 10.1016/0022-2836(92)90697-I contributor: fullname: Hommel – volume: 11 start-page: 2431 year: 1991 ident: 10.1074/jbc.271.26.15367_bib31 publication-title: Mol. Cell. Biol. contributor: fullname: Engler – volume: 76 start-page: 2016 year: 1985 ident: 10.1074/jbc.271.26.15367_bib12 publication-title: J. Clin. Invest. doi: 10.1172/JCI112202 contributor: fullname: Stern – volume: 1266 start-page: 83 year: 1995 ident: 10.1074/jbc.271.26.15367_bib28 publication-title: Biochim. Biophys. Acta doi: 10.1016/0167-4889(94)00224-3 contributor: fullname: Adam – volume: 53 start-page: 223 year: 1986 ident: 10.1074/jbc.271.26.15367_bib19 publication-title: Br. J. Cancer doi: 10.1038/bjc.1986.39 contributor: fullname: Cowley – volume: 49 start-page: 353 year: 1995 ident: 10.1074/jbc.271.26.15367_bib7 publication-title: Prog. Nucleic Acid Res. Mol. Biol. doi: 10.1016/S0079-6603(08)60055-0 contributor: fullname: Campion – volume: 47 start-page: 117 year: 1994 ident: 10.1074/jbc.271.26.15367_bib26 publication-title: Biochem. Pharmacol. doi: 10.1016/0006-2952(94)90444-8 contributor: fullname: Holt – volume: 33 start-page: 103 year: 1985 ident: 10.1074/jbc.271.26.15367_bib21 publication-title: Gene (Amst.) doi: 10.1016/0378-1119(85)90120-9 contributor: fullname: Yanisch-Perron – volume: 49 start-page: 367 year: 1995 ident: 10.1074/jbc.271.26.15367_bib25 publication-title: Biochem. Pharmacol. doi: 10.1016/0006-2952(94)00423-J contributor: fullname: Richter – volume: 248 start-page: 384 year: 1989 ident: 10.1074/jbc.271.26.15367_bib11 publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Hollenberg – volume: 2 start-page: 599 year: 1991 ident: 10.1074/jbc.271.26.15367_bib14 publication-title: Cell Regul. doi: 10.1091/mbc.2.8.599 contributor: fullname: Ebner – volume: 259 start-page: 1604 year: 1993 ident: 10.1074/jbc.271.26.15367_bib5 publication-title: Science doi: 10.1126/science.8456283 contributor: fullname: Shing – volume: 105 start-page: 205 year: 1991 ident: 10.1074/jbc.271.26.15367_bib20 publication-title: Gene (Amst.) doi: 10.1016/0378-1119(91)90152-2 contributor: fullname: Clare – volume: 82 start-page: 488 year: 1985 ident: 10.1074/jbc.271.26.15367_bib22 publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.82.2.488 contributor: fullname: Kunkel – volume: 247 start-page: 7609 year: 1972 ident: 10.1074/jbc.271.26.15367_bib18 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)44568-7 contributor: fullname: Savage – volume: 242 start-page: 331 year: 1987 ident: 10.1074/jbc.271.26.15367_bib13 publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Gan – volume: 258 start-page: 13606 year: 1983 ident: 10.1074/jbc.271.26.15367_bib1 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)43958-5 contributor: fullname: Massagué – volume: 1 start-page: 13 year: 1989 ident: 10.1074/jbc.271.26.15367_bib6 publication-title: Prog. Growth Factor Res. doi: 10.1016/0955-2235(89)90038-0 contributor: fullname: Campbell – volume: 267 start-page: 6205 year: 1991 ident: 10.1074/jbc.271.26.15367_bib4 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)42682-8 contributor: fullname: Higashiyama – volume: 28 start-page: 6373 year: 1989 ident: 10.1074/jbc.271.26.15367_bib9 publication-title: Biochemistry doi: 10.1021/bi00441a033 contributor: fullname: Winkler – volume: 267 start-page: 383 year: 1995 ident: 10.1074/jbc.271.26.15367_bib35 publication-title: Science doi: 10.1126/science.7529940 contributor: fullname: Clackson – volume: 194 start-page: 3 year: 1991 ident: 10.1074/jbc.271.26.15367_bib24 publication-title: Methods Enzymol. doi: 10.1016/0076-6879(91)94004-V contributor: fullname: Sherman – volume: 232 start-page: 1250 year: 1986 ident: 10.1074/jbc.271.26.15367_bib10 publication-title: Science doi: 10.1126/science.2422759 contributor: fullname: Schreiber – volume: 96 start-page: 125 year: 1990 ident: 10.1074/jbc.271.26.15367_bib23 publication-title: Gene (Amst.) doi: 10.1016/0378-1119(90)90351-Q contributor: fullname: Landt |
SSID | ssj0000491 |
Score | 1.5889512 |
Snippet | Although binding of epidermal growth factor (EGF) and transforming growth factor alpha (TGFalpha) to the EGF receptor (EGFR) is mutually competitive, their... Although binding of epidermal growth factor (EGF) and transforming growth factor alpha (TGF alpha ) to the EGF receptor (EGFR) is mutually competitive, their... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 15367 |
SubjectTerms | Amino Acid Sequence Animals Base Sequence Cells, Cultured Chick Embryo DNA Primers - chemistry Epitopes ErbB Receptors - metabolism Growth Substances - chemistry Humans Ligands Mitogens - chemistry Molecular Sequence Data Mutagenesis, Site-Directed Protein Structure, Secondary Sequence Alignment Sequence Homology, Amino Acid Structure-Activity Relationship Transforming Growth Factor alpha - chemistry Transforming Growth Factor alpha - immunology Valine - chemistry |
Title | The significance of valine 33 as a ligand-specific epitope of transforming growth factor alpha |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8663070 https://search.proquest.com/docview/15658193 |
Volume | 271 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZoOcClgpaK8PQBIaFow669rxyjklKhEg4JUk9YfhYkuoma5MC_Z8b2ZrdFCDhwWSWbXW808-34sz2ej5BXY-6U0iUmhVmb5CqtEyBHLsmdzLRJmdIa53TP5tXson43zafdckF37r96Gs6Br3Hn7D94e9conIDP4HM4gtfh-Nd-x6QMTAHy2wGADUL7SCY5R1UZOfz-7VI2JsFNlnjV0K7gtV6FdIGWx-IMwiUM0TdfoyTP0O_K7XPZbleZ57OhnFMoONKqyO0C79YYgNyVChPew35WASqSRNX4eaf09VHq9xLCmL2xdIVlAKKSyKSbr8AU5370xXQQFkq1t9GXBQWWCDPWD6YQjINUR-yZ4XuQ-fkl7AMPwrCv9AiaG7Fy1Lu1X2F79kmcfj4_F4vpxWKP3GUQnFBvYf5h1vXeeVRZjP81Lm3DE97ebv8mlfnN-MTzlMUDchAdQicBGQ_JHdsckqNJIzfLqx_0NfUpv34t5ZDcO2kddUS-gDtpHzh06WgADuWcyjWV9BZwaAQOXtkHDg3AoQE41APnEZmfThcnZ0kU30h0XrJNorPCZkw5OTZOq1xVY10aXta2Zq6qNLzgFdbrKpzTvMiUrWsz5grrXtcSKPEx2W-WjX1MqFS8gIiQam1cnlpZK27TzChVWTA_KwbkTWtFsQoVVoTPjKhyARYXYHHBSuEtPiAvWzMLMA-ubcnGLrdr-BmoNAxGBuQ4WH_XVg2cGvq1J3-89Sm5H1LycX7tGdnfXG_tc7K3NtsXHiI_AegFhM0 |
link.rule.ids | 315,782,786,4030,27934,27935,27936 |
linkProvider | Multiple Vendors |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+significance+of+valine+33+as+a+ligand-specific+epitope+of+transforming+growth+factor+alpha&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Puddicombe%2C+S+M&rft.au=Chamberlin%2C+S+G&rft.au=MacGarvie%2C+J&rft.au=Richter%2C+A&rft.date=1996&rft.issn=0021-9258&rft.volume=271&rft.issue=26&rft.spage=15367&rft.epage=15372&rft_id=info:doi/10.1074%2Fjbc.271.26.15367&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon |